| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |